AdaptHealth Corp.

Annual Trend FY 2018 FY 2019 FY 2020 FY 2021 FY 2022 FY 2023 FY 2024 FY 2025
Net Income $69.3m ($678.9m) $90.4m ($70.8m)
Net Income From Continuing Operations $73.1m ($674.8m) $94.8m ($66.0m)
Depreciation and amortization, including patient equipment depreciation $62.6m $76.4m $258.1m $351.2m $382.8m $365.3m $381.9m
Amortization of deferred financing costs $478k $1.3m $1.9m $5.4m $5.2m $5.2m $5.7m $5.7m
Depreciation Amortization Depletion $351.2m $382.8m $365.3m $381.9m
Depreciation And Amortization $351.2m $382.8m $365.3m $381.9m
Deferred income tax expense (benefit) ($2.9m) $895k ($21.1m) $22.4m $18.0m ($62.6m) $32.0m $47.2m
Deferred Income Tax $18.0m ($62.6m) $32.0m $47.2m
Deferred Tax $18.0m ($62.6m) $32.0m $47.2m
Goodwill impairment $0 $0 $830.8m $13.1m $128.0m
Asset Impairment Charge $0 $830.8m $13.1m $128.0m
Reduction in the carrying amount of operating lease right-of-use assets $0 $28.6m $32.3m $31.9m $32.8m $31.1m
Loss on extinguishment of debt $0 $0 $2.3m $0
Operating lease obligations $0 ($12.8m) ($22.5m) ($22.0m) ($35.9m) ($37.9m)
Operating leases $22.5m $22.0m $35.9m $37.9m
Write-off of assets subject to operating lease obligations $0 $0 ($8.5m) ($14.7m) ($6.7m) ($2.6m)
Write-off of operating lease obligations $0 $0 $8.5m $14.7m $6.7m $2.6m
Net (loss) income $24.3m ($12.9m) ($58.7m) $158.2m $73.1m ($674.8m) $94.8m ($66.0m)
Equity-based compensation $883k $11.1m $18.7m $25.3m $22.4m $22.5m $14.9m $21.9m
Change in fair value of warrant liability $7.7m $135.4m ($53.2m) ($17.2m) ($34.5m) ($4.0m) $0
Reduction in the carrying amount of finance lease right-of-use assets $0 $0 $5.9m $11.1m $15.3m
Change in fair value of interest rate swaps, net of reclassification adjustment ($547k) $11.4m ($2.8m) ($2.9m) ($2.9m) ($1.8m) ($367k) $0
Payment of contingent consideration from an acquisition $0 ($1.9m) $0
Gain on sale of businesses (note 4) $0 $0 ($32.6m)
Other $816k ($5.6m) ($3.6m) ($285k) $350k $2.1m $2.7m
Accounts receivable ($22.0m) ($20.2m) ($29.5m) ($29.7m) ($209k) ($28.9m) ($26.2m) $31.0m
Inventory $2.3m ($1.3m) ($19.4m) ($14.9m) ($6.3m) $15.5m ($28.1m) ($11.5m)
Prepaid and other assets ($1.6m) ($9.6m) ($10.8m) $2.7m ($13.1m) ($20.3m) $27.3m ($61.1m)
Operating liabilities $2.7m $14.2m $136.6m ($83.4m) ($57.1m) $41.0m $33.8m $139.3m
Purchases of equipment and other fixed assets ($9.9m) ($21.3m) ($39.8m) ($203.3m) ($391.4m) ($337.5m) ($306.1m) ($382.4m)
Proceeds from the sale of businesses, net of cash disposed $0 $0 $120.4m
Proceeds from the sale of assets $0 $0 $5.3m $0
Payments for cost method investments ($8.7m) ($1.1m) ($731k) ($128k) $0 $0
Receipt of contingent consideration from the sale of assets $0 $0 $1.2m
Proceeds from borrowings on lines of credit $24.8m $55.5m $591.3m $1.2b $0 $50.0m $253.5m $0
Repayments of finance lease obligations ($37.3m) ($39.1m) ($42.2m) ($16.2m) ($6.8m) ($9.9m) ($18.5m)
Payments for shares purchased under share repurchase program ($20.0m) $0 $0 ($14.0m) ($29.3m) $0 $0
Proceeds from the exercise of stock options $0 $12.3m $2.5m $587k $742k $0
Proceeds received in connection with employee stock purchase plan $101k $1.0m $1.6m $2.0m $999k $1.2m
Payments for tax withholdings from vesting of restricted stock units ($507k) ($59k) ($3.6m) ($3.5m) ($5.8m) ($2.1m) ($2.7m)
Payments of contingent consideration and deferred purchase price from acquisitions ($13.0m) ($4.0m) ($25.2m) ($14.5m) ($2.5m) ($5.3m) ($212k)
Cash at beginning of period $25.2m $76.9m $100.0m $149.6m $46.3m $77.1m $109.7m $106.1m
Unpaid equipment and other fixed asset purchases at end of period $12.6m $8.5m $7.9m $13.9m $24.2m $35.9m $56.1m $65.9m
Assets subject to finance lease obligations $0 $0 $32.1m $17.9m $31.4m
Finance lease obligations $0 $0 ($32.1m) ($17.9m) ($31.4m)
Write-off of assets subject to finance lease obligations $0 $0 ($513k) ($1.6m)
Write-off of finance lease obligations $0 $0 $513k $1.6m
Deferred purchase price in connection with acquisitions $500k $1.6m $33k $4.5m $457k $137k $0 $355k
Beginning Cash Position $149.6m $46.3m $77.1m $109.7m
Cash Flow From Continuing Financing Activities ($66.1m) ($92.5m) ($198.9m) ($302.2m)
Cash Flow From Continuing Investing Activities ($411.2m) ($357.3m) ($310.3m) ($303.2m)
Change In Inventory ($6.3m) $15.5m ($28.1m) ($11.5m)
Change In Other Current Liabilities ($88.3m) $8.5m $898k $108.2m
Change In Other Working Capital ($28.0m) ($31.2m)
Change In Prepaid Assets ($13.1m) ($20.3m) $27.3m ($61.1m)
Change In Receivables ($209k) ($28.9m) ($26.2m) $31.0m
Change In Working Capital ($108.0m) ($25.1m) ($26.1m) $66.6m
Changes In Account Receivables ($209k) ($28.9m) ($26.2m) $31.0m
Changes In Cash ($103.4m) $30.9m $32.6m ($3.6m)
End Cash Position $46.3m $77.1m $109.7m $106.1m
Financing Cash Flow ($66.1m) ($92.5m) ($198.9m) ($302.2m)
Free Cash Flow ($17.6m) $143.2m $235.8m $219.4m
Gain Loss On Investment Securities ($56.1m) ($20.1m) ($36.3m) ($4.4m)
Gain Loss On Sale Of Business $0 $0 ($32.6m)
Investing Cash Flow ($411.2m) ($357.3m) ($310.3m) ($303.2m)
Issuance Of Capital Stock $278.9m $0 $0
Net Business Purchase And Sale ($19.0m) ($19.7m) ($9.5m) $78.0m
Net PPE Purchase And Sale ($391.4m) ($337.5m) ($306.1m) ($382.4m)
Operating Gains Losses ($20.1m) ($36.3m) ($2.1m) ($32.6m)
Other Non Cash Items $37.2m $43.4m $49.9m $54.9m
Proceeds From Stock Option Exercised $4.1m $2.6m $1.7m $1.2m
Purchase Of Business ($19.0m) ($19.7m) ($9.5m) ($42.4m)
Purchase Of PPE $21.3m $39.8m $203.3m ($391.4m) ($337.5m) ($306.1m) ($382.4m)
Repurchase Of Capital Stock ($14.0m) ($29.3m) $0 $0
Sale Of Business $0 $0 $120.4m
Stock Based Compensation $22.4m $22.5m $14.9m $21.9m
Net cash provided by operating activities $68.4m $60.4m $195.6m $275.7m $373.9m $480.7m $541.8m $601.8m
Payments for business acquisitions, net of cash acquired ($86.3m) ($63.5m) ($769.3m) ($1.6b) ($19.0m) ($19.7m) ($9.5m) ($42.4m)
Net Investment Purchase And Sale ($731k) ($128k) $0 $0
Purchase Of Investment ($731k) ($128k) $0 $0
Sale Of Investment $0 $0
Net Other Investing Changes $5.3m $1.2m
Net cash used in investing activities ($96.3m) ($84.9m) ($815.7m) ($1.8b) ($411.2m) ($357.3m) ($310.3m) ($303.2m)
Issuance Of Debt $0 $50.0m $253.5m $0
Long Term Debt Issuance $0 $50.0m $253.5m $0
Net Issuance Payments Of Debt ($36.2m) ($51.8m) ($179.9m) ($268.5m)
Net Long Term Debt Issuance ($36.2m) ($51.8m) ($179.9m) ($268.5m)
Repayments on long-term debt and lines of credit ($24.8m) ($194.1m) ($547.5m) ($827.3m) ($20.0m) ($95.0m) ($423.5m) ($250.0m)
Payments of debt financing costs $0 $0 ($3.2m) ($6.4m) $0
Long Term Debt Payments ($36.2m) ($101.8m) ($433.3m) ($268.5m)
Repayment Of Debt ($36.2m) ($101.8m) ($433.3m) ($268.5m)
Common Stock Issuance $278.9m $0 $0
Net Common Stock Issuance ($14.0m) ($29.3m) $0 $0
Common Stock Payments ($14.0m) ($29.3m) $0 $0
Distributions to noncontrolling interests ($300k) ($1.3m) ($800k) ($1.1m) ($2.0m) ($2.5m) ($5.6m) ($7.0m)
Net Other Financing Charges ($20.0m) ($14.1m) ($20.8m) ($34.9m)
Net cash used in financing activities $48.8m $76.1m $643.2m $1.6b ($66.1m) ($92.5m) ($198.9m) ($302.2m)
Net (decrease) increase in cash $20.9m $51.7m $23.1m $49.7m ($103.4m) $30.9m $32.6m ($3.6m)
Change In Cash Supplemental As Reported ($103.4m) $30.9m $32.6m ($3.6m)
Cash paid for interest $7.3m $23.1m $35.8m $73.6m $108.9m $126.2m $122.1m $101.2m
Cash paid for income taxes, net of refunds $405k $1.3m $7.5m $14.8m $14.9m $14.8m $14.1m $24.3m

Values abbreviated: b = billions, m = millions, k = thousands. Per share data in USD.